Rupesh Hemendra Shah

Rupesh Hemendra Shah

Active Director Designated Partner DIN 00029134
DIN 00029134 First appointment Jul 2001 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 10 active board seats
Past companies 10 historical roles
Total affiliations 20 Since Jul 2001
Shareholding value Locked Premium profile
Directorship timeline
First appointment 16 Jul 2001
Active appointments 13
Total timeline records 20

Appointment history

Since 2001
Atc Medicare Private Limited Director · 2022 - 2026
Current
Dhruvi Healthcare Private Limited Managing Director · 2022 - 2026
Current
Coffeebean Flavours Private Limited Director · 2022 - 2026
Current
Anila Medical Private Limited Nominee Director · 2021 - 2026
Current
Meditree Lifecare Llp Designated Partner · 2021 - 2026
Current
Accs Logistics Private Limited Director · 2020 - 2026
Current
Atc Pharma Private Limited Nominee Director · 2019 - 2026
Current
Relicorp Logistics Llp Designated Partner · 2015 - 2026
Current
Medimore Pharma Private Limited Director · 2006 - 2026
Current
Rr Shipping Private Limited Director · 2004 - 2026
Current
Current
Yashvi Pharma Private Limited Director · 2003 - 2026
Current
Dhruvi Pharma Private Limited Managing Director · 2001 - 2026
Current
Goldencross Pharma Limited Director · 2010 - 2016
Previous
Medic Remedies Private Limited Director · 2009 - 2017
Previous
Globus Healthcare Limited Additional Director · 2009 - 2010
Previous
Golden Temple Pharma Private Limited Additional Director · 2006 - 2007
Previous
Previous
Gmp Technical Solutions Private Limited Director · 2006 - 2010
Previous
Lancet Pharma Private Limited Director · 2006 - 2015
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available